The adjustment in price target by a major analyst like Morgan Stanley can have a mixed impact. While maintaining an Overweight rating indicates a positive outlook on the stock, the reduction in price target could signal a tempered expectation for the stock's short-term growth potential. Investors might view this as a slight negative, but the overall bullish stance should mitigate any significant downside.